Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance-Reference-Cited by-同舟云学术

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance

Published:2018-07 Issue: Volume:458 Page:74-82
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Bidmon Nicole,Kind Sonja,Welters Marij J.P.,Joseph-Pietras Deborah,Laske Karoline,Maurer Dominik,Hadrup Sine Reker,Schreibelt Gerty,Rae Richard,Sahin Ugur,Gouttefangeas Cécile,Britten Cedrik M.,van der Burg Sjoerd H.

Funder

Wallace Coulter Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference23 articles.

1. Immune monitoring of islet and pancreas transplant recipients;Abreu;Curr. Diabetes Rep.,2013

2. Generation of TCR-engineered T cells and their use to control the performance of T cell assays;Bidmon;J. Immunol.,2015

3. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the cancer Vaccine Consortium;Britten;Cancer Immunol. Immunother.,2009

4. T cell assays and MIATA: the essential minimum for maximum impact;Britten;Immunity,2012

5. Immunological monitoring to rationally guide AAV gene therapy;Britten;Front. Immunol.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical Modeling of the Tumor–Immune System with Time Delay and Diffusion;Axioms;2023-02-10

2. Non-viral transfection technologies for next-generation therapeutic T cell engineering;Biotechnology Advances;2021-07

3. Stability and bifurcation analysis of a tumor-immune system with two delays and diffusion;Mathematical Biosciences and Engineering;2021

4. Generation of TCR-engineered reference cell samples to control T-cell assay performance;Methods in Enzymology;2020

5. Flow Cytometry in Cancer Immunotherapy: Applications, Quality Assurance, and Future;Cancer Immunology;2020